Clinical Trial Update: Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ALD-401 delivered via intracarotid infusion for ischemic stroke; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ALD-401

Snippet

Sponsor: Aldagen | Conditions: Stroke, Ischemic Stroke | Phase 2 | Status: UNKNOWN